PS.

Estimated value

—

goods

Awarded value

—

Suppliers

19

5 SME

Lots

8

8 awarded

Published

11 Feb 2021

Total lots

8

Awarded

8

0 pending

Estimated total

—

Awarded total

—

Lot 3cancelled

Infliximab Subcutaneous

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000
Lot 4cancelled

Adalimumab

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000
Lot 5cancelled

Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000
Awarded to 2 suppliers
AL
Accord-UK Ltd
MP
medac Pharma LLP
SME
Lot 6cancelled

Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000
Awarded to 1 supplier
AU
Accord UK Ltd
Lot 7cancelled

Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000
Awarded to 1 supplier
NP
Nordic Pharma Ltd
SME
Lot 8cancelled

Methotrexate (25mg per 1 ml concentration ) pre-filled syringes

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000
Awarded to 1 supplier
NP
Nordic Pharma Ltd
SME
Lot 1cancelled

Etanercept

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000
Awarded to 3 suppliers
SL
Sandoz Ltd
PL
Pfizer Ltd
BI
Biogen Idec Ltd.
Lot 2cancelled

Infliximab IV

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000